{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/coordinating-complexity-delivering-global-diagnostic-imaging-studies-across-modalities-and#webpage",
"url": "https://www.fortrea.com/insights/coordinating-complexity-delivering-global-diagnostic-imaging-studies-across-modalities-and",
"name": "Coordinating complexity: Delivering global diagnostic imaging studies across modalities and patient populations",
"description": "This case study highlights how Fortrea successfully delivered complex global diagnostic imaging studies across multiple imaging modalities, patient populations, therapeutic areas, and international locations. Diagnostic imaging research requires highly coordinated execution involving radiology, radiopharmacy, medical physics, surgery, laboratory services, and clinical operations teams working within strict procedural timelines. The study demonstrates how careful planning, patient pathway coordination, radiotracer manufacture and validation, imaging compliance measures, and cross-functional collaboration supported successful delivery despite operational complexity. Fortrea implemented structured site readiness strategies, imaging qualification processes, early validation activities, and multidisciplinary coordination to address challenges related to imaging protocol complexity, resource constraints, patient recruitment, retention, and site capacity limitations. The case study also highlights the importance of imaging standardization, radiotracer management, risk mitigation, and proactive engagement across study teams to support efficient and reliable study execution. By combining operational expertise with a structured approach to patient pathways, site readiness, and imaging workflows, Fortrea enabled the successful delivery of high-quality imaging data across PET, CT, SPECT, MRI, ultrasound, ECG-based imaging, and theranostic imaging studies. The outcome demonstrates how early planning, collaboration, and operational excellence can improve study readiness, support protocol adherence, and ensure successful global diagnostic imaging study delivery."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Coordinating complexity: Delivering global diagnostic imaging studies across modalities and patient populations",
"item": "https://www.fortrea.com/insights/coordinating-complexity-delivering-global-diagnostic-imaging-studies-across-modalities-and"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/coordinating-complexity-delivering-global-diagnostic-imaging-studies-across-modalities-and#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/coordinating-complexity-delivering-global-diagnostic-imaging-studies-across-modalities-and#webpage"
},
"headline": "Coordinating complexity: Delivering global diagnostic imaging studies across modalities and patient populations",
"description": "This case study highlights how Fortrea successfully delivered complex global diagnostic imaging studies across multiple imaging modalities, patient populations, therapeutic areas, and international locations. Diagnostic imaging research requires highly coordinated execution involving radiology, radiopharmacy, medical physics, surgery, laboratory services, and clinical operations teams working within strict procedural timelines. The study demonstrates how careful planning, patient pathway coordination, radiotracer manufacture and validation, imaging compliance measures, and cross-functional collaboration supported successful delivery despite operational complexity. Fortrea implemented structured site readiness strategies, imaging qualification processes, early validation activities, and multidisciplinary coordination to address challenges related to imaging protocol complexity, resource constraints, patient recruitment, retention, and site capacity limitations. The case study also highlights the importance of imaging standardization, radiotracer management, risk mitigation, and proactive engagement across study teams to support efficient and reliable study execution. By combining operational expertise with a structured approach to patient pathways, site readiness, and imaging workflows, Fortrea enabled the successful delivery of high-quality imaging data across PET, CT, SPECT, MRI, ultrasound, ECG-based imaging, and theranostic imaging studies. The outcome demonstrates how early planning, collaboration, and operational excellence can improve study readiness, support protocol adherence, and ensure successful global diagnostic imaging study delivery.",
"genre": "Case Study",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2026-07/global-imaging-studies.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-07-28",
"dateModified": "2026-07-28",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-07/diagnostic-imaging-studies.pdf",
"encodingFormat": "application/pdf"
}
}
]
}